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Abstract
Background: CCCTC binding factor (CTCF) is a highly conserved zinc finger protein, which is involved in
chromatin organization, local histone modifications, and RNA polymerase II-mediated gene transcription. CTCF may
act by binding tightly to DNA and recruiting other proteins to mediate its various functions in the nucleus. To
further explore the role of this essential factor, we used a mass spectrometry-based approach to screen for novel
CTCF-interacting partners.
Results: Using biotinylated CTCF as bait, we identified upstream binding factor (UBF) and multiple other
components of the RNA polymerase I complex as potential CTCF-interacting partners. Interestingly, CTCFL, the
testis-specific paralog of CTCF, also binds UBF. The interaction between CTCF(L) and UBF is direct, and requires the
zinc finger domain of CTCF(L) and the high mobility group (HMG)-box 1 and dimerization domain of UBF. Because
UBF is involved in RNA polymerase I-mediated ribosomal (r)RNA transcription, we analyzed CTCF binding to the
rDNA repeat. We found that CTCF bound to a site upstream of the rDNA spacer promoter and preferred non-
methylated over methylated rDNA. DNA binding by CTCF in turn stimulated binding of UBF. Absence of CTCF in
cultured cells resulted in decreased association of UBF with rDNA and in nucleolar fusion. Furthermore, lack of
CTCF led to reduced binding of RNA polymerase I and variant histone H2A.Z near the rDNA spacer promoter, a
loss of specific histone modifications, and diminished transcription of non-coding RNA from the spacer promoter.
Conclusions: UBF is the first common interaction partner of CTCF and CTCFL, suggesting a role for these proteins
in chromatin organization of the rDNA repeats. We propose that CTCF affects RNA polymerase I-mediated events
globally by controlling nucleolar number, and locally by regulating chromatin at the rDNA spacer promoter, similar
to RNA polymerase II promoters. CTCF may load UBF onto rDNA, thereby forming part of a network that maintains
rDNA genes poised for transcription.
Background
CTCF is a conserved and ubiquitously expressed pro-
tein, which binds DNA through an 11-zinc finger (ZF)
domain and organizes chromatin into loops [1]. CTCF
may act as an insulator, mainly by inhibiting inappropri-
ate interactions between regulatory elements on adjacent
or distal chromatin domains. In many instances, CTCF
binds cognate sites in a methylation-sensitive manner,
allowing the regulation of imprinted loci, such as the
H19/Igf2 locus. A testis-specific paralog of CTCF has
been characterized, called CTCFL or BORIS (brother of
the regulator of imprinted sites), which has strong simi-
larity to CTCF in the ZF domain and has overlapping
DNA-binding specificity [2]. CTCF and CTCFL share
little similarity outside their ZF region. To date, no
common interaction partners of CTCF and CTCFL have
been reported.
Genomewide studies have revealed a multitude of
CTCF binding sites, whose distribution over chromo-
somes correlates with gene density [3]. The cohesin
complex, which mediates sister chromatid cohesion in
dividing cells, was shown to colocalize with CTCF on
CTCF binding sites [4-6]. Recent data suggest that
CTCF/cohesin are together involved in the organization
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cific sites, and cohesin in turn mediating chromosomal
interactions [7]. CTCF may also colocalize with the variant
histone H2A.Z [8]. When CTCF is bound near an RNA
polymerase II-regulated transcription start site (TSS), it is
mostly located upstream of a DNAse I hypersensitive site
(HS) which in turn precedes the TSS [9]. These data sug-
gest a global role played by CTCF as an organizer of RNA
polymerase II-mediated transcription. By contrast, we
have shown that loss of a CTCF-binding site affects chro-
matin looping and local histone modifications in the
mouse b-globin locus, without significantly perturbing
transcription [10]. Collectively, these data indicate that
CTCF is able to regulate the balance between active and
repressive chromatin modifications near its binding sites,
with different outcomes in terms of transcription. CTCF
may control epigenetic modifications by binding to the
chromatin remodeling factor CHD8 [11].
The nucleolus is a nuclear subcompartment in which
the 18S, 5.8S and 28S ribosomal (r)RNAs are synthe-
sized by RNA polymerase I, processed and, together
with 5S rRNA, assembled into ribosomes [12]. Ribosome
biogenesis is tightly coordinated with cellular metabo-
lism and cell proliferation. In all organisms, ribosomal
genes are repeated many times, so that enough rRNA
can be produced when demand for ribosomes is high.
However, even in metabolically active cells, a significant
number of repeats are not transcribed. In human and
mouse, there are approximately 200 rDNA repeats per
haploid genome (that is, ~400 per interphase nucleus).
T h e s ea r ec l u s t e r e di nf i v en ucleolar organizer regions
(NORs), located on different chromosomes. Two pro-
moters have been identified within the mouse rDNA
repeat: the spacer promoter and the gene promoter. The
spacer promoter is located upstream of the gene promo-
ter within the intergenic spacer (IGS). Transcription
from this promoter is thought to serve a regulatory
function and gives rise to non-coding RNAs (ncRNAs
or nc-rRNAs). Transcription from the gene promoter
yields a ~13 kb (or 47S) ribosomal precursor RNA (pre-
rRNA), which is processed in a complex manner into
the mature 18S, 5.8S and 28S rRNAs.
Efficient transcription from the ribosomal gene pro-
moter requires a multiprotein complex including selec-
tivity factor (SL)1, RNA polymerase I, and upstream
binding factor (UBF) [13]. UBF is an abundant nucleolar
protein that contains several HMG domains involved in
DNA binding [14]. UBF binds dynamically throughout
the rDNA repeat [15], and not only plays a role as a
transcriptional activator of RNA polymerase I, but also
in transcription elongation [16] and in the maintenance
of the specific chromatin structure of NORs [17]. More
recent data suggest that UBF is involved in determining
the number of active rDNA genes [18].
To better understand the function of CTCF, we
performed a screen for CTCF-interacting proteins. We
found that both CTCF and CTCFL interact directly with
UBF. CTCF binds immediately upstream of the riboso-
mal spacer promoter in a methylation-sensitive manner,
and activates spacer promoter transcription. CTCF bind-
ing controls the loading of UBF onto rDNA, and the
binding of RNA polymerase I and H2A.Z near the
spacer promoter. Our data show that CTCF regulates
the local epigenetic state of the rDNA repeat. CTCF
may organize RNA polymerase I and II promoters in a
similar manner. We proposet h a tC T C Fb i n d i n gm a i n -
tains rDNA repeats in a state poised for activation.
Results
Characterization of biotinylated CTCF
To identify CTCF-binding partners, we used a biotinyla-
tion tagging and proteomics approach (Figure 1A) [19].
As CTCF levels are crucial for cell proliferation, we did
not generate cell lines overexpressing biotinylated
CTCF. Instead, we used homologous recombination in
embryonic stem (ES) cells to generate a novel Ctcf
knock-in allele. DNA encoding a small peptide tag of 23
amino acids was inserted in the last exon of the Ctcf
gene, before the stop codon of CTCF (Figure 1B). This
tag is biotinylated upon addition of the bacterial biotin
ligase enzyme, BirA. Southern blot and PCR analysis
identified homologous recombination events (Figure
1C). The resulting allele was termed Ctcf
bio-neo,a si t
contains both the biotinylation sequence and the neo-
mycin resistance gene.
Ctcf
bio-neo/+ ES cells were transfected with a plasmid
expressing Cre recombinase to remove the neomycin
resistance gene and generate the Ctcf
bio allele (Figure
1B). Then, using homologous recombination, the BirA
biotin ligase was placed into the Rosa26 locus (data not
shown). Genotyping and verification of these targeting
events was performed by PCR (Figure 1D). This method
yielded an ES cell line expressing normal CTCF (from
the wild type allele) and biotinylated CTCF (from the
Ctcf
bio allele). The biotin tag is placed at the C-terminus
of CTCF, hence the fusion protein was called CTCF-bio.
Ctcf
bio-neo ES cells were also injected into blastocysts to
generate knock-in mice. These mice were subsequently
crossed with a mouse line expressing BirA from the
Rosa26 locus [20]. From these mice, CTCF-interacting
proteins could be identified in a developmental and tis-
sue specific manner.
CTCF-bio cannot be distinguished from untagged
CTCF with anti-CTCF antibodies because the biotin
tag does not cause a major difference in migration
behavior in SDS-PAGE gels (Figure 1E, upper panel).
However, CTCF-bio is detected using streptavidin-
based methods (Figure 1E, middle panel). Our results
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similar levels (Figure 1E). Pull-down assays using ES
cell extracts with streptavidin-coupled magnetic beads
results in efficient and specific binding of CTCF-bio to
the beads (Figure 1F). Size fractionation experiments
suggest that CTCF and CTCF-bio are present in high
molecular weight complexes in ES cells (Figure 1G).
Furthermore, CTCF-bio binds known CTCF target
s i t e ss u c ha st h ec-Myc insulator and the 3” HS1 of
b-globin (Figure 1H). Importantly, mice expressing
CTCF-bio are viable and fertile (data not shown).
Combined, these results indicate that CTCF-bio is a
functional protein.
CTCF and CTCFL interact with UBF
CTCF-bio was purified from ES cell nuclear extracts
under mild conditions using streptavidin-coupled mag-
netic beads (Figure 2A). Known CTCF-interacting part-
ners, including Yin Yang (YY)-1, poly(ADP-ribose)
polymerase (Parp)1 and nucleophosmin, co-precipitated
with CTCF-bio (see Additional file 1, Figure S1A),
further confirming that CTCF-bio is a functional fusion
Figure 1 Characterization of biotinylated CCCTC binding factor (CTCF). (A) Identification of CTCF-binding partners. CTCF (light grey boxes)
was tagged with biotin at its C-terminus (biotinylated lysine indicated by a star) and pulled down, and interacting proteins were identified by
mass spectrometry. Zinc fingers are indicated by dark grey box; proline-rich region with AT hook. (B) Targeting of mouse Ctcf. The Ctcf gene is
shown on the top line. Exons (black boxes are coding, open boxes are non-coding) and probes (1, 2) are indicated. X = XbaI, P = PstI. Targeting
construct is shown in the middle. Bio = biotin-tag, black triangles = loxP sites, Neo
r = PMC1-neomycin cassette. After targeting, Ctcf
bio-neo was
obtained. Cre-mediated excision yielded the Ctcf
bio knock-in allele (bottom line). (C) Southern blot analysis. Digested embryonic stem (ES) cell
DNA was analyzed by Southern blotting using probes 1 or 2. Alleles are indicated. (D) PCR analysis of mouse tail DNA. (E) Expression of biotin
tagged CTCF (CTCF-bio). Nuclear thymic extracts were analyzed by western blotting. Coomassie staining shows total protein. (F) CTCF-bio pull-
down assay with streptavidin beads. Nuclear ES cell extracts were incubated with streptavidin-coupled magnetic beads. Input (i) = 5% of nuclear
extract, (u) = 6% of unbound fraction, b = material bound to beads. (G) Size fractionation of CTCF and CTCF-bio. Size fractionated nuclear
extracts were analyzed by western blotting. Molecular mass markers are indicated. V0 = void volume, input = nuclear extract (5%). (H) Chromatin
immunoprecipitations. CTCF-bio precipitated with streptavidin-coupled magnetic beads from formaldehyde fixed nuclei bound known CTCF sites
(b-globin 3” HS1 and c-Myc insulator).
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late CTCF-bio were sufficiently mild to allow identifica-
tion of novel interaction partners. Proteins co-purifying
with CTCF-bio were detected by mass spectrometry and
classified by BLAST searches; 58 of these co-purified
specifically with CTCF in more than one pull-down
experiment (data not shown). We noted that several
CTCF-interacting proteins are involved in RNA poly-
merase I-mediated transcription (see Additional File 2
Table S1), including UBF and proteins that form a
complex with UBF, such as the large subunit of RNA
polymerase I (RPA194) and its associated factor PAF53
[21]. Moreover, the 40 kDa and 135 kDa subunits of
RNA polymerase I (RPA40, RPA135) and polymerase
associated factor (PAF)49 were pulled down by CTCF-
bio (data not shown). These data suggest that CTCF
interacts with essential components of the machinery
that regulates the synthesis of rRNA. We therefore
decided to further analyze the function of CTCF in
rRNA transcription.
Figure 2 Interaction of CCCTC binding factor (CTCF) and CTCFL with upstream binding factor (UBF). (A) Biotin tagged CTCF (CTCF-bio)
interacted with UBF and RNA polymerase I in embryonic stem (ES) cells. Nuclear extracts from ES cells expressing CTCF-bio and control ES cells
(-) were incubated with streptavidin beads, and CTCF-bio was purified with interacting proteins. Extracts were treated with (+) or without (-)
benzonase for 2 hours at 4°C. Western blots were incubated with the indicated antibodies (CTCF-bio detected with streptavidin-coupled
horseradish peroxidase). UBF was detected as a doublet consisting of UBF1 and UBF2; RPA194 = the large subunit of RNA polymerase I. B =
bound fraction; i = input (5%). (B) Both CTCF and CTCFL interacted with UBF. Cells were transfected with different cDNAs (indicated below the
lanes). CTCFL was not tagged. Immunoprecipitations (IPs) were carried out using anti-Flag antibodies. Western blots were incubated with
antibodies against the indicated proteins. (C) Green fluorescent protein (GFP) tagged CTCF deletion mutants. The regions of CTCF used for
making the different fusion proteins are indicated by lines. (D) UBF interacts with the zinc-finger domain of CTCF. GFP tagged CTCF deletion
mutants (in (C)) were co-expressed with Flag tagged UBF in HEK293T cells. All fusion proteins are expressed at similar levels (input). After a Flag
pull-down (IP), co-precipitating proteins were detected with an antibody against GFP. Lane numbers correspond to mutant numbers in (C).
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blot analysis confirmed the CTCF-bio interaction
with UBF and the large subunit of RNA polymerase I
(Figure 2A). We also detected interaction of CTCF-bio
and UBF in lung (see Additional file 1, Figure S1B)
and thymus (not shown), indicating that the associa-
tion between these two proteins is not confined to ES
cells. When ES cell nuclear extracts were treated with
benzonase, the CTCF-bio interaction with UBF
remained detectable, indicating that the interaction is
not mediated by DNA (Figure 2A). Co-immunoprecipi-
tation (co-IP) with anti-CTCF antiserum revealed an
interaction between untagged CTCF and UBF (see
Additional file 1, Figure S1C).
As CTCF and CTCFL are very similar in their ZF
domains, we tested the possibility that CTCFL also
interacts with UBF. We overexpressed a Flag-tagged
form of UBF in 293T cells, either alone or with CTCFL,
and performed a Flag co-IP on extracts from these cells.
Flag-UBF brings down endogenous CTCF and overex-
pressed CTCFL (Figure 2B). Interestingly, diminished
interaction between CTCF and UBF was detected in
cells expressing CTCFL. These results identify UBF as
the first common interaction partner of CTCF and
CTCFL, and also indicate that CTCF and CTCFL com-
pete for binding to UBF.
Experiments with bacterially purified proteins revealed
a direct interaction between the CTCF and CTCFL ZF
domains and the UBF dimerization domain plus HMG-
box 1 (see Additional file 3, Figure S2). Using CTCF
deletion mutants [22], we observed that both the N-
and C-terminal ZFs of CTCF interacted with UBF (Fig-
ure 2C, D). Taken together, our data show that CTCF
and CTCFL bind UBF directly via their ZF domains.
Identification of a CTCF binding site upstream of the
rDNA spacer promoter
To provide a functional explanation for the CTCF-UBF
interaction, we tested binding of both proteins using chro-
matin immunoprecipitation (ChIP) in mouse embryonic
fibroblasts (MEFs). Consistent with published experiments
[15,23], UBF bound throughout the enhancer/promoter
regions and transcribed portion of the mouse rDNA
repeat, with hardly any enrichment in the IGS (Figure 3B,
blue line). By contrast, ChIP of CTCF revealed a highly
specific accumulation immediately upstream of the rDNA
spacer promoter (Figure 3B, black line). We also detected
CTCF binding to the rDNA spacer promoter region in
extracts of adult thymus from wild type and CTCF-bio-
expressing mice (see Additional file 4, Figure S3). The
CTCF binding coincided with (and was adjacent to) RNA
polymerase I enrichment (Figure 3B, red line). Strong
RNA polymerase I association to the spacer promoter
relative to the gene promoter has also been shown by
others [24-26].
The ChIP experiments suggest the presence of a CTCF
binding site near the spacer promoter of the mouse
rDNA locus. An algorithm was devised to search for
potential binding sites within this locus. One site (R30),
which conforms to the CTCF consensus sequence [3], is
present in the spacer promoter area (Figure 3C). A probe
(also called R30) was designed and tested in band-shift
analysis, using nuclear extracts of non-transfected cells
and of cells overexpressing CTCF. The known chicken
lysozyme F1 site was used as control. We detected bind-
ing of endogenous CTCF and bacterially purified glu-
tathione-S-transferase (GST)-CTCF-ZF to the R30 probe
(Figure 3D, lanes 6 to 10 and 11 to 13, respectively).
Competition experiments indicated that CTCF bound
the FI probe less efficiently than it did R30, (Figure 3E,
lanes 3 and 4). These data demonstrate that CTCF binds
R30 through its ZF domain.
Previous studies have shown that mouse, rat and ham-
ster rDNA repeats share significant sequence similarity
in the spacer promoter region of the IGS [27]. Rat and
hamster rDNA also contain the CTCF binding site (Fig-
ure S4, Additional file 5). Based on alignment informa-
tion, we mutated three residues within R30, and
p e r f o r m e db a n d - s h i f t sw i t hn o r m a la n dm u t a n tR 3 0
probes. As shown in Figure 3E, CTCF bound less effi-
ciently to mutant R30 (lanes 5 and 7). Combined, these
results identify a novel CTCF binding site in the mouse
rDNA repeat that is conserved in rat and hamster.
T h eI G So ft h eh u m a nr D N Ar e p e a ti sc o m p l e t e l y
divergent in sequence from the mouse IGS (see Addi-
tional file 6, Figure S5A to C) and the presence of a
spacer promoter has not been accurately described.
Nevertheless, we identified two potential CTCF binding
sites in the rDNA repeat, which were 0.9 kb and 5.1 kb
upstream of the ribosomal gene promoter (called H42.1
and H37.9, respectively, for their respective positions)
(see Additional file 6, Figure S5B). ChIP analysis
revealed occupancy of CTCF at both sites, although
binding was more prominent in the region near H42.1
than near H37.9 (see Additional file 7, Figure S6A). As
K562 cells express both CTCF and CTCFL, we also
tested whether CTCFL could bind the human rDNA
repeat. Protein-DNA complexes were immunoprecipi-
tated with two different CTCFL antibodies. CTCFL
bound both H37.9 and H42.1, with a preference for site
H42.1 (see Additional file 7, Figure S6A). We also
detected binding of UBF to these rDNA regions (see
Additional file 7, Figure S6A) and using sequential
(ChIP-reChIP) analysis, found that CTCF and UBF
were present on the same rDNA repeats (see Additional
file 7, Figure S6B).
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Page 5 of 21Figure 3 Identification of a novel CCCTC binding factor (CTCF) binding site near the ribosomal (r)DNA spacer promoter. (A) Outline of
mouse rDNA repeat. Transcription (spacer promoter = ncRNA, gene promoter = pre-rRNA, right-pointing arrows), chromatin
immunoprecipitation (ChIP) primers (downward-pointing arrows), organization of 47S pre-rRNA (external transcribed spacers (ETS), internal
transcribed spacers (ITS), 18S, 5.8S and 28S rRNA, CTCF consensus site (grey box) and enhancer repeats (white boxes)), are indicated. (B) Binding
of CTCF, upstream binding factor (UBF) and RNA polymerase I to mouse rDNA was analyzed by ChIP on formaldehyde-fixed mouse embryonic
fibroblast (MEF) nuclei. (C) CTCF binding site in mouse rDNA. The R30 sequence is shown, with CTCF consensus site (underlined), highly
conserved CTCF site residues (dots), deviation from consensus (asterisk) and CpG dinucleotides (gray). Nucleotides in bold were mutated
(R30mut). (D, E) Band-shift analysis. Increasing amounts of HEK293T extracts (non-transfected (n) or transfected with CTCF), were incubated with
the indicated probes (a known CTCF binding site (F1, chicken lysozyme, R30 and R30mut). Competitor was added in 300-fold excess. Band shifts
were also performed with purified bacterial proteins (glutathione-S-transferase (GST) only (G) and zinc fingers (ZF) of CTCF tagged with GST. (F)
CTCF and UBF bound R30 DNA together. HEK293T extracts (increasing amounts indicated, transfected with GFP-CTCF (+) Flag-UBF (1 to 5×) or
the C-terminal domain of CTCF tagged with GFP (Ct, see Figure 2C) were incubated with R30. aC = addition of anti-CTCF; pr = addition of anti-
UBF and anti-FLAG (preclear). (G) CTCF and UBF bound human rDNA together. HEK293T extracts (increasing amounts indicated, transfected with
GFP-CTCF (+) or Flag-UBF (1 to 7×) were incubated with H42.1. Asterisks indicate UBF binding to H42.1. aC = addition of anti-CTCF. (H) UBF
weakly bound human rDNA. HEK293T extracts (increasing amounts indicated), transfected with Flag-UBF (1 to 5×) were incubated with H42.1.
Asterisks indicate UBF binding to H42.1 Cp = cold probe; UBF = addition of anti-UBF; UBF(p) = addition of anti-UBF and anti-FLAG before
incubation with probe (preclear).
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electrophoretic mobility shift assay (EMSA) analysis (see
Additional file 7, Figure S6C). Nuclear extracts from
cells transfected with CTCF showed stronger binding to
H42.1 and H37.9 rDNA probes compared with extract
from mock-transfected cells. The specificity of the bind-
ing was shown by competition with unlabeled probes
and by supershift assays using anti-CTCF antibody.
Incubation with an anti-actin antibody, used as a nega-
tive control, did not produce supershifts (data not
shown). Together, these results demonstrate that CTCF
associates upstream of the gene promoter in human
rDNA and suggest that CTCF and UBF are bound
together to the rDNA.
We next tested whether the in vitro binding of CTCF
to DNA influences binding of UBF. Extracts of cells
transfected with GFP-CTCF or Flag-UBF were incubated
separately or together with the H42.1 probe, and bind-
ing of CTCF and UBF was examined by EMSA (Figure
3 G ,H ) .B i n d i n go fU B Fa l o n et ot h eH 4 2 . 1p r o b e
resulted in a relatively weak signal (Figure 3G, lane 9;
Figure 3H, lane 1; asterisks), that was specific for UBF
(Figure 3H, lanes 2, 3, 6). Increasing the amount of UBF
in the reaction eventually led to enhanced and coopera-
tive binding of UBF (Figure 3G, lanes 10 to 12; Figure
3H, lanes 4, 5). Interestingly, binding of CTCF to H42.1
resulted in enhanced binding of UBF at much lower
levels of this protein (Figure 3G, compare lanes 4 to 8
with 9 to 12). These data suggest that CTCF helps to
load UBF onto rDNA.
CTCF binds rDNA in a methylation-sensitive manner
The CTCF R30 binding site in the mouse rDNA repeat
includes two CpG residues (Figure 3C), which might be
methylated in vivo. The CpG residues are conserved in
rat and hamster (see Additional file 5, Figure S4). As
CTCF often binds DNA in a methylation-sensitive man-
ner, we tested whether the in vitro methylation of these
two sites in R30 affected CTCF binding. We found that
this was the case to some extent, as CTCF bound the
non-methylated R30 probe slightly more efficiently, and
this probe was a better competitor than methylated R30
(see Additional file 8, Figure S7A).
Human 37.9 and 42.1 CTCF binding sites contain three
CpG residues instead of two (not shown). One of these
overlaps with the highly conserved GG dinucleotide that
is part of the ‘core’ CTCF binding site (Figure 3C). The
second CpG is conserved between human and mouse
rDNA sites (it is the 5"end CpG in R30) (Figure 3C),
whereas the third CpG in the human rDNA sites is not
conserved between mouse and human, nor between 37.9
and 42.1 (not shown). We used SssI methyltransferase to
completely methylate the human H37.9 and H42.1
probes (see Additional file 8, Figure S7B). Interestingly,
CTCF binding to these fully methylated probes was
severely reduced (Figure 4A). These data indicate that
CTCF binds rDNA in a methylation-sensitive manner
in vitro. Both the position and number of methylated
CpG residues appear to influence CTCF binding to
cognate sites.
To test whether DNA methylation might interfere
with CTCF binding to the rDNA in vivo,w ep e r f o r m e d
ChIP-chop experiments. Before quantitative PCR, the
input and CTCF-enriched DNA samples were subjected
to digestion with the methylation-sensitive enzyme
HpaII or the methylation-insensitive enzyme MspI.
CTCF did not bind HpaII-resistant (that is, methylated)
H42.1 rDNA (Figure 4B). Similar data were obtained for
H37.9 rDNA (not shown). These results indicate that
CTCF prefers non-methylated over methylated riboso-
mal DNA in vivo. A ChIP-chop assay performed on
mouse ES cell DNA also showed CTCF binding to non-
methylated rDNA (data not shown).
Fully methylated rDNA repeats are thought to be
inactive [28]. To investigate an in vivo correlation
between CTCF binding in the spacer promoter and
methylation status of the rDNA repeats, we used 3T3L1
cells. These cells can be differentiated into adipocytes,
which results in the repression of rRNA transcription by
more than 50% [29]. Increased heterochromatin features
at the rDNA promoter accompany this repression
[29,30]. ChIP analysis revealed binding of CTCF, UBF
and RNA polymerase I at the spacer promoter in undif-
ferentiated 3T3L1 cells (Figure 4C, left panel). As
reported previously [29], UBF and RNA polymerase I
binding to the rDNA repeat was reduced in differen-
tiated 3T3L1 cells (Figure 4C, right panel). CTCF bind-
ing was also significantly reduced (Figure 4C, right
panel). These data suggest that increasing heterochro-
matinization in vivo significantly affects binding of
CTCF, UBF and RNA polymerase I. We propose that
in vivo CTCF binds rDNA repeats in a methylation-
sensitive manner.
CTCF regulates nucleolar number, and is required for UBF
and RNA pol I binding near the spacer promoter
To examine the physiological significance of a CTCF-
UBF interaction and of CTCF binding to the rDNA
spacer promoter, we generated a system to efficiently
deplete CTCF in vitro. MEFs were isolated from mice
homozygous for a Ctcf conditional knockout allele [31],
and CTCF was deleted by infecting confluent MEFs
with a replication-deficient lentivirus expressing Cre
recombinase [10]. After 4 days of culture, only very low
levels of CTCF protein were detected on western blot
(Figure 5A). Immunofluorescence analysis revealed that
a small proportion of MEFs still expressed CTCF (data
not shown), suggesting that these were not infected by
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Page 7 of 21Figure 4 CCCTC binding factor (CTCF) binding to ribosomal (r)DNA is methylation-sensitive. (A) Influence of methylation on the binding
of CTCF to rDNA. Band-shift assays using human H37.9 and H42.1 rDNA probes, either completely methylated with SssI methyltransferase
(methylated probe) or non-methylated (control probe) on HEK293T extracts, transfected or not with CTCF. Competition was assessed by adding
increasing amounts of non-labeled probe. In some cases, extracts were incubated with the indicated antibodies. (B) CTCF prefers non-
methylated rDNA in vivo. Chromatin from K562 cells was immunoprecipitated with anti-CTCF (CTCF ChIP). Purified DNA was left uncut (mock
digestion), or digested with HpaII or MspI. Quantitative PCR was then performed with H42.1 primers, both on non-precipitated K562 DNA (input)
and on DNA enriched for CTCF binding sites (CTCF ChIP). Note the high content of HpaII-resistant H42.1 rDNA in K562 cells (input), which
represents methylated rDNA. In the CTCF-enriched sample, the HpaII-resistant rDNA was not present, suggesting that CTCF does not bind well to
methylated rDNA. (C) ChIP analysis on (left panel) undifferentiated and (right panel) differentiated 3T3L1 cells. Nuclei were fixed with 1%
formaldehyde, and protein-DNA complexes were immunoprecipitated with antibodies against the indicated proteins (the large subunit of RNA
polymerase I (RPA194), CTCF, upstream binding factor (UBF) and acetylated histone H4). The position of the primer sets (upward arrows, see also
ChiP2 in Figure 6A), spacer promoter (right-pointing arrow with ncRNA (part A), enhancer repeats (white rectangles) and gene promoter (right-
pointing arrow with pre-rRNA)) is indicated on the rDNA. The horizontal axis of the panels is co-aligned with the rDNA underneath and shows
distance in base pairs.
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Page 8 of 21the virus. MEFs lacking CTCF could be maintained as a
confluent layer for several days (data not shown), but
they could not be passaged, because they are severely
impaired in division. These results are in line with
in vivo data showing that CTCF is essential for the pro-
liferation and growth of b-selected T cells [31].
Next, we investigated the intracellular distribution of
UBF in MEFs. Interestingly, deletion of CTCF reduced
the number of UBF-positive spots, and thus the number
of nucleoli, in MEFs (Figure 5B, C). However, the aver-
age size of a UBF-positive area, and thus that of a
nucleolus, was larger in CTCF-deleted MEFs. As a result
the total fluorescence intensity (and hence the level) of
UBF was similar in CTCF-deleted and normal MEFs, a
result supported by western blot analysis (not shown)
and data in T cells [31]. We conclude that deletion of
CTCF in MEFs results in fusion of nucleoli but does not
affect UBF levels.
CTCF binding to the rDNA spacer promoter was
virtually undetectable in MEFs treated with Cre virus
(Figure 6B, right-hand panels, red line) compared with
non-treated MEFs (Figure 6B, left-hand panels, red line).
In the absence of CTCF, binding of UBF and RNA poly-
merase I was severely reduced (Figure 6B, right hand
panels, blue and green line, respectively). Remarkably,
the absence of CTCF did not significantly perturb RNA
polymerase I binding to the gene promoter. Thus,
CTCF exerts a local influence.
In mouse ES cells, distribution of CTCF, UBF and RNA
Pol I over the rDNA repeat, as analyzed by ChIP, was
similar to that in MEFs (see Additional file 9, Figure S8).
We used an RNA interference (RNAi)-based approach to
knock down Ctcf mRNA in ES cells. Real time PCR and
immunofluorescence analysis suggested knock down of
CTCF of > 70% after 4 days of culture. Although the
depletion of CTCF in ES cells was less effective than Cre-
treatment of Ctcf
f/f MEFs, this reduction did lead to a loss
in UBF and RNA pol I binding (see Additional file 9, Fig-
ure S8B). These results confirm the role of CTCF in UBF
and RNA polymerase I localization.
CTCF maintains specific histone marks at the spacer
promoter
Given the role of CTCF in epigenetic chromatin remo-
deling near its binding sites, we examined the distribu-
tion of specific histone marks across the rDNA
regulatory region in the presence and absence of CTCF.
ChIP analysis in normal MEFs revealed peaks of histone
H3 acetylation, H3K4 dimethylation and H2A.Z just
upstream of the CTCF binding site (Figure 6C, left
panel). In the absence of CTCF H2A.Z, H3K4 dimethy-
lation and H3 acetylation (that is, markers of ‘active’
chromatin and of insulator sites) were clearly downregu-
lated (Figure 6C, right panel). A control ChIP experi-
ment revealed similar amounts of histone H3 in the
p r e s e n c eo ra b s e n c eo fC T C F( s e eF i g u r eS 9 A ,A d d i -
tional file 10), showing that the reduction in H2A.Z,
H3K4me2 and H3ac levels is specific. Furthermore,
ChIP analysis in the human rDNA repeat revealed speci-
fic accumulation of H2A.Z, H3K4me2 and H3ac at both
CTCF binding sites in K562 cells (see Figure S9C, Addi-
tional file 10). Combined, our data suggest that CTCF is
required for local histone modifications and the accu-
mulation of a histone variant at the spacer promoter.
B e c a u s ew ef o u n dt h a tC T C Fi sr e q u i r e df o rH 2 A . Z
accumulation at the rDNA spacer promoter, we tested
whether this also occurs with H2A.Z sites near RNA
polymerase II-dependent genes. In the absence of
CTCF, H2A.Z was indeed lost from the c-Myc promoter
Figure 5 CCCTC binding factor (CTCF) regulates nucleolar
number. (A) Efficient deletion of CTCF in mouse embryonic
fibroblasts (MEFs). MEFs carrying the conditional Ctcf
f knockout allele
were infected (+) or not (-) with a lentivirus expressing Cre
recombinase. After 4 days, cell extracts were analyzed for residual
CTCF. Mta2 was used as loading control. In MEFs, Ctcf deletion with
lentiviral Cre was very efficient, with > 90% of cells infected. (B, C)
Distribution of upstream binding factor (UBF) in MEFs. Primary MEFs
carrying the conditional Ctcf
f knockout allele were either infected
(+CrE) or not (-CrE) with a lentivirus expressing Cre recombinase.
Cells were fixed, and incubated with antibodies against UBF
(because both the CTCF and UBF antibodies used for
immunofluorescence analysis were mouse monoclonals, we could
not perform a combined CTCF/UBF stain. (B) Single image; (C)
immunofluorescence results from several images were quantified.
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can mediate the deposition of this histone variant close
to RNA polymerase I and II promoters. The relatively
constant levels of histone H3 in the rDNA locus in nor-
mal and Cre-treated MEFs (see Additional file 10, Figure
S9A) indicate that the observed loss of histone modifica-
tions and H2A.Z are not caused by a reduction in
nucleosomes in the absence of CTCF. Furthermore, the
changes in DNA binding by specific proteins (for exam-
ple, UBF and RNA polymerase I) seen in the absence of
CTCF, are not the result of changes in the total amount
of these proteins (data not shown).
CTCF activates transcription from the spacer promoter
We next examined the effect of a CTCF deletion on
steady state RNA levels using total RNA isolated from
Figure 6 CCCTC binding factor (CTCF) organizes chromatin on ribosomal (r)DNA. (A) Outline of mouse rDNA repeat. The position of the
primer pairs (1 to 7) used in the second chromatin immunoprecipitation (ChIP2; panel B) is indicated by upward-pointing arrows. For
comparison, the primers used in the first ChIP (ChIP1; Figure 3) are also shown. For other explanations, see Figure 3A. (B) Binding of CTCF,
upstream binding factor (UBF) and RNA polymerase I to the mouse spacer promoter. ChIP analysis was performed on mouse embryonic
fibroblasts (MEFs) homozygous for the conditional Ctcf knockout allele (Ctcf
f/(F). MEFs were either (right panels) infected or not (left panels) with
a lentivirus expressing Cre recombinase. Nuclei were fixed with 1% formaldehyde, and protein-DNA complexes were immunoprecipitated with
antibodies against the indicated proteins (control = rabbit IgG). The upper and lower panels show the same results, but with a different vertical
axis. Numbers on the horizontal axis refer to primer pairs. (C) Binding of modified and variant histones to the mouse spacer promoter. ChIP
analysis was performed as described above. Protein-DNA complexes were immunoprecipitated with antibodies against the indicated proteins
(control = rabbit IgG). Numbers on the horizontal axis refer to primer pairs.
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f/f MEFs that were either treated or not treated with
Cre virus. Using northern blot analysis, we found similar
ratios of pre-rRNA (47S) to Gapdh mRNA in CTCF
depleted MEFs (Figure 7B). Furthermore, the ratio of
mature 18S rRNA to Gapdh mRNA was comparable in
normal and CTCF-depleted cells. These results indicate
that a deletion of CTCF does not affect steady state
rRNA amounts in confluent non-dividing fibroblasts.
Using nuclear run-on analysis, we investigated transcrip-
tion from spacer and gene promoters in the presence
and absence of CTCF. Deletion of CTCF significantly
reduced transcription from the spacer promoter but did
not affect transcription from the ribosomal gene promo-
ter (Figure 7C). These results show that CTCF can acti-
vate transcription from the spacer promoter
independently of the gene promoter.
We next examined the influence of CTCF on rRNA
biogenesis in a cell type other than MEF. For these
experiments, we used mouse ES cells, because RNAi-
mediated knockdown of CTCF is effective in these cells.
We investigated spacer and gene-promoter derived tran-
scription in the presence or absence of CTCF using
real-time PCR and fluorescent in situ hybridization
(FISH). For the latter, we used probes against spacer
promoter-derived transcripts (’ncRNA’ probe), together
with a previously described probe (’pre-rRNA’ probe
[32]) that covers the unstable 5” end of the external
transcribed spacer (see Figure 7A for position of the
probes on the rDNA). RNA FISH experiments showed
that both the ncRNA probe (green) and the pre-rRNA
probe (red) were located inside ES cell nucleoli (see
Additional file 11, Figure S10C-E). Whereas the pre-
rRNA signal was detected at a relatively constant level
in each ES cell nucleolus, the ncRNA signal varied with
respect to intensity and number of spots (on average ~4
per cell). These FISH experiments indicate that only a
small subset of the rDNA repeats express ncRNA, con-
sistent with recently published data [26]. Remarkably,
ncRNA spots were often located at the periphery of the
nucleolus, whereas pre-rRNA was detected throughout
(see Figure S10C, D, Additional file 11). Our results sug-
gest that ncRNA and pre-rRNA transcription can be
independently regulated in space and time inside the
nucleoli of ES cells.
Real-time PCR analysis suggests that pre-rRNA levels
are reduced in ES cells lacking CTCF (Figure 7D). We
also quantified pre-rRNA levels by measuring the fluor-
escence intensity in FISH experiments in non-treated,
control RNA-treated, and CTCF RNAi-treated ES cells.
Consistent with the PCR data, the pre-rRNA transcript
was mildly affected in cells knocked down for CTCF
(Figure 7E). Thus, in ES cells, lack of CTCF resulted in
a very mild reduction of pre-rRNA levels, to ~80% of
control. By contrast, both real-time PCR experiments
using two different primers sets (Figure 7D) and RNA
FISH data (see Additional file 11, Figure S10F) showed
that ncRNA levels were significantly decreased in ES
cells lacking CTCF. Combined with the run-on analysis
in MEFs (Figure 7C) these results strongly suggest that
CTCF activates transcription from the spacer promoter,
an activity that is independent of cell type.
Discussion
We have identified UBF as the first common interaction
partner of CTCF and CTCFL, emphasizing a role for
these proteins in the organization of rDNA chromatin.
It will be interesting to determine how CTCFL influ-
ences rRNA transcription in vivo, as in normal tissues
this protein is expressed in a very restricted manner [2],
whereas its expression is upregulated in various types of
cancers [33]. The ZF domain of CTCF and CTCFL
mediates the interaction with UBF. In CTCF, this
domain has also been shown to be responsible for inter-
action with other proteins, including CHD8 [11]. Inter-
estingly, a ZF-dependent, pan-nucleolar localization of
CTCF was described in K562 cells, which correlated
with poly (ADP-ribosyl)ation and growth arrest of cells
[34]. The pan-nucleolar distribution of CTCF indicates
that the protein must be bound to rRNA and/or nucleo-
lar proteins in addition to rDNA. It is therefore not sur-
prising that CTCF function is different in K562 cells
compared with MEFs or ES cells. Post-translational
modifications may alter the function, localization and
interactions of CTCF in a cell type-specific manner. We
conclude that the ZF-domain of CTCF is a versatile
nucleic acid and protein-protein interaction surface,
explaining why it is so conserved.
Previously, the Xenopus laevis rDNA repeat was
reported to contain multiple weak CTCF binding sites
near its spacer promoter [35]. Although the physiological
significance for rDNA transcription was not investigated
in that study, the result is consistent with our data. The
importance of CTCF binding near the spacer promoter is
emphasized by the observation that the mouse binding
site is conserved in rat and hamster. Furthermore, we
identified two CTCF sites in the human rDNA (H37.9
and H42.1, respectively) upstream of the gene promoter.
We found a specific accumulation of H2A.Z, H3K4me2
a n dH 3 a ca tC T C Fb i n d i n gs i t e si nt h eh u m a na n d
mouse rDNA repeats. Interestingly, enrichment of the
acetylated histones H3 and H4 and of TATA binding
protein (TBP) was observed 100 bp upstream of site
H42.1, whereas UBF accumulates 3’ to this site [36].
Thus, despite the fact that the IGS regions of mouse and
human are not conserved (see Additional file 6, Figure
S5A to C), critical factors and chromatin modifications
are similarly organized around CTCF binding sites in
rDNA (see Additional file 6, Figure S5D). In fact, our
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Page 11 of 21Figure 7 CCCTC binding factor (CTCF) activates spacer promoter transcription. (A) Transcribed portion of mouse ribosomal (r)DNA.
Transcription initiation (spacer promoter = ncRNA, gene promoter = pre-rRNA, right-pointing arrows) and positions of run-on (left-pointing
arrows), northern blot and fluorescent in situ hybridization (lines) probes are indicated. (B) Northern blot analysis. Total RNA from Ctcf
f/f primary
mouse embryonic fibroblasts (MEFs) (either treated (+) or not (-) with Cre) was analyzed sequentially with probes against the 47S pre-rRNA [32]
and Gapdh (two samples per genotype shown, > 10 independent samples per genotype analyzed. (C) Spacer promoter transcription in the
absence of CTCF. Nuclear run-on of spacer and gene promoter in Ctcf
f/f MEFs (Cre-treated (+) or not (-)). The suppression effect of a-amanitin on
RNA polymerase II-mediated transcription was measured. Left panel shows Actin and Histone H3 genes; a typical run-on is shown on the right.
The graph shows the relative transcription activity of spacer and gene promoter (three independent experiments; *P = 0.005, Student t-test). (D,
E) CTCF knockdown in embryonic stem (ES) cells. Cells were transfected with a pSUPER plasmid to knock down CTCF (controls were either no
transfection, or transfection with a control vector). After 4 days, cells were harvested for (D) RNA analysis by PCR, or fixed and analyzed by
fluorescent in situ hybridization (E). ncRNA was determined twice with independent primers (1, 2), Ctcf and pre-rRNA were determined four
times (SD indicated). Taking the average of the four ncRNA experiments showed a reduction of spacer transcript in CTCF-depleted cells to 39 ±
22% (mean ± SD). (E) Quantification was performed with > 300 cells per treatment (SEM indicated).
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CTCF sites near the RNA polymerase I-regulated spacer
promoter and near RNA polymerase II promoters [9] is
also similar. First, CTCF binds ~200 bp upstream of the
TSS in both types of promoters, and an HS is present
between the TSS and CTCF binding site. Furthermore,
H2A.Z and H3K4me2 accumulate ~200 to 300 bp
upstream of the CTCF binding site. Enrichment of H2A.
Z at CTCF binding sites appears to be a general phenom-
enon [8,9,37]. In RNA polymerase II promoters, H2A.Z
and H3K4me2 marks are associated with active or
‘poised’ promoters. We propose that binding of CTCF to
the spacer promoter also maintains rDNA repeats
‘poised’ for transcription.
With one high affinity binding site per mouse rDNA,
and with CTCF preferring non-methylated (and thus
active) rDNA repeats, it is expected that only a small
number of DNA-bound nucleolar CTCF molecules
would be present. By contrast, UBF is abundantly pre-
sent in the nucleolus, where it binds rDNA with low
specificity [23] and is highly dynamic [15,38]. Thus, a
UBF-CTCF interaction is expected to be transient. How-
ever, the interaction is crucial, as CTCF binding
enhances UBF binding both in vitro and in vivo. Nucleo-
lar UBF in turn ensures that rDNA repeats remain
accessible to RNA polymerase I [18]. UBF, as part of the
architectural HMG-box protein family, could change the
topology of the rDNA, thereby facilitating binding of
other factors [39], and allowing formation of small ~175
bp DNA loop structures called enhanceosomes [40]. In
addition, CTCF and UBF may together recruit RNA
polymerase I to the spacer promoter. Binding by CTCF
to components of the RNA polymerase I complex would
aid in this recruitment.
The biological function of the spacer promoter and
the ncRNA transcript that is generated from it are still
not completely understood. Early experiments suggested
that the spacer promoter and the enhancer region act
together to stimulate pre-rRNA transcription [27,41].
More recent data have shown that ncRNAs generated
from the spacer promoter are unstable; transcripts are
rapidly processed and degraded, and only the 3’ end
(~150 nucleotides) of the transcript, which matches the
rDNA gene promoter, is bound to the nucleolar remo-
deling complex (NoRC) and is required for the estab-
lishment and maintenance of inactive rDNA repeats
[24,30]. In this context, the spacer promoter transcript
functions in rDNA silencing instead of activation.
Recent data implicate UBF in the balance between
active and inactive rRNA genes, via a ‘pseudosilencing’
mechanism that is reversible and does not involve DNA
methylation [18]. Thus, there appear to be two different
epigenetic mechanisms that regulate the number of
active rRNA genes. An attractive hypothesis is that
CTCF, by binding to the spacer promoter of non-
methylated (and thus active) rDNA repeats, and by
interacting with UBF and ‘loading’ it onto these repeats,
is involved in the ‘pseudo-silencing’ mechanism and
maintains rDNA repeats ‘poised’ for transcription. At
the same time, by generating spacer promoter tran-
scripts, CTCF is ‘feeding’ NoRC with its 3’ end degrada-
tion product, allowing this protein complex to function
in a second epigenetic rRNA gene silencing mechanism.
Consistent with this notion, ncRNA transcription
appears to take place on a small subset of hypomethy-
lated mouse rDNA repeats [26].
CTCF not only acts locally, but also regulates nucleo-
lar number. Results in MEFs are consistent with data
in T cells, where we found that the number of rDNA-
positive signals decreases when CTCF is deleted in vivo
[31]. Interestingly, B23 (or nucleophosmin) is a protein
partner of CTCF, and B23-enriched insulator sequences
are tethered to the nucleolar rim in a CTCF-dependent
manner [42]. B23 is important for nucleolar structure
[43]. Moreover, the borders of lamina-associated
domains, detected by lamin B1, are demarcated by
CTCF binding sites [44]. Lamin B1 interacts with B23,
and is also involved in maintaining nucleolar structure
[45]. We hypothesize that control of nucleolar number
by CTCF is linked to its global function as an architec-
tural factor, in association with proteins such as B23
and lamin B1.
Ribosome biogenesis controls cell growth and prolif-
eration, as it determines the protein synthesis capacity
of a cell. Recently, we showed that CTCF positively reg-
ulates cell growth in rapidly dividing thymocytes [31]. In
the present study we detected multiple components of
the RNA polymerase I complex in the mass spectrome-
try analysis of CTCF-bio-interacting partners. Knock-
down of CTCF in ES cells resulted in slightly lowered
levels of pre-rRNA. Conversely, under conditions of
repressed pre-rRNA transcription, as in differentiated
3T3L1 cells [29], CTCF binding to the spacer promoter
is reduced. Combined, these data suggest a link between
CTCF, rRNA synthesis and cell growth control, whereby
CTCF appears to act at a local and a global level.
Conclusions
We show that CTCF and CTCFL bind UBF directly.
CTCF organizes the local epigenetic state of rDNA
repeats by regulating the binding UBF and RNA poly-
merase I and of other crucial components, and by alter-
ing chromatin modifications near its binding site. By
tightly binding the rDNA spacer promoter, CTCF may
enhance UBF binding and ensure that rDNA repeats are
accessible to RNA polymerase I. CTCF binding at the
spacer promoter stimulates transcription of non-coding
RNA from the spacer promoter. The local organization
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regulated spacer promoter and near RNA polymerase II
promoters is remarkably similar. The CTCF-dependent
enrichment of H2A.Z and H3K4me2 near the spacer
promoter indicates that CTCF binding maintains rDNA
repeats ‘poised’ for transcription.
Methods
Accession numbers and primers
We used mouse (accession number BK000964), human
(U13369), rat (X04084) and hamster (DQ235090) rDNA
sequences for alignments, to design primers for PCR
and ChIP experiments and for probe generation. Pri-
mers used in all the different experiments are shown in
Tables S2 tp S7 (Additional file 12, 13, 14, 15, 16, 17
respectively).
Antibodies and cDNAs
CTCF mouse monoclonal antibodies were from BD
Biosciences (Breda, NL), and CTCFL polyclonal rabbit
antibodies (18337) were from Abcam. CTCFL (#4) poly-
clonal rabbit antibodies are described elsewhere (Sleutels
et al, manuscript in preparation). The anti-CTCF (N3)
and anti-RPA194 rabbit polyclonal antisera have been
described previously [31,46]. Anti-histone H2A.Z
(ab4174), anti-dimethyl-histone H3 (Lys4) (ab7766) and
anti-histone H3 (ab1791) antibodies were from Abcam.
Anti-acetyl histone H3 (06-599) and anti-acetyl Histone
H4 (06-866) antibodies were from Upstate (Millipore,
Amsterdam, NL). Anti-UBF (sc-13125) and anti-actin
(sc-8432) antibodies were from Santa Cruz Biotechnolo-
gies (Santa Cruz, CA, USA). Streptavidin-HRP
(RPN1231VS) and secondary HRP-labeled anti-mouse
(NA931VS) and anti-rabbit antibodies (NA934V) were
from Amersham (GE Healthcare, Uppsala, Sweden).
Anti-His antibody was from Qiagen (Valencia, CA,
USA), and anti-Flag M2 antibody was from Sigma Che-
mical Co. (St Louis, MO, USA).
His-tagged UBF fusion proteins were generated by
PCR using mouse UBF cDNA from a Flag-tagged UBF
construct as template (kind gift of Dr I. Grummt). Pri-
mers contained NheIa n dBamHI sites for subcloning
into the pET28a vector. GST-tagged fusions of mouse
CTCF and CTCFL were amplified using mouse CTCF
(IMAGE 6825952) and CTCFL (Sleutels et al,m a n u -
script in preparation) cDNAs as templates. cDNAs were
cloned into plasmid pGEX-3X and purified (glutathione-
Sepharose 4B; Amersham Biosciences). GST-tagged
fusion proteins derived from chicken CTCF have been
described previously [47].
Mass spectrometry
For mass spectrometry samples were treated and ana-
lyzed as described [48]. Data analysis and protein
identification was performed as reported [49]. The Mas-
cot search algorithm (version 2.0; MatrixScience) was
used for searching against the NCBI database (taxonomy:
Mus musculus). The Mascot score cut-off value for a
positive protein hit was set to 60. Individual peptide tan-
dem mass spectrometry (MS/MS) spectra with scores of
< 40 were checked manually, and either interpreted as
valid identifications or discarded. A number of CTCF-bio
interacting proteins are listed in Table S1 (see Additional
file 2). It should be noted that CTCF is difficult to purify
under the mild conditions that are required to isolate
associating proteins, although CTCF binds DNA tightly,
t h em a j o r i t yo fi t sp r o t e i n - protein interactions are of a
transient nature.
Affinity chromatography and size fractionation
Nuclear extracts were prepared as described previously
[50]. Salt concentration in the extract was adjusted to
100 mmol/l NaCl. Unless stated differently, all IP and
pull-down reactions were performed in IP buffer (100
mmol/l NaCl, 0.3% NP40, 20 mmol/l Hepes pH8, 0.2
mmol/l EDTA, 10 mmol/l MgCl2, with protease inhibi-
tors) (Complete; Roche). Benzonase (Novagen) was
added where indicated to remove DNA and RNA.
Streptavidin pull-down assays were performed as
described previously [19], with the exception that the
wash buffer and binding buffer were the same as the IP
buffer described above. For IPs, nuclear extracts were
pre-cleared at 4°C (Protein A sepharose beads, Sigma).
Washes were performed at 4°C in wash buffer (100
mmol/l NaCl, 20 mmol/l Tris pH7.5, 0.3% NP40 and
protease inhibitors). IPs were performed by adding anti-
bodies to the samples and incubating for 1 hour at 4°C.
Subsequently, protein-A sepharose beads were added,
and incubation was continued for another hour at 4°C
while rotating. Beads were washed six times with wash
buffer.
Flag-IPs were performed using the same protocol as
for IPs, except that anti-Flag M2 agarose (Sigma) incu-
bation was performed for 3h at 4°C.
His-tagged proteins were bound to nickel-nitrilotria-
cetic (Ni-NTA) beads (Qiagen) in low salt buffer
(20 mmol/l Hepes pH 7.5, 100mmol/l KCl, 10 mmol/l
b-mercaptoethanol and 10% glycerol v/v). Proteins
were purified by extensive washing of the beads, first
in low-salt buffer, followed by washing in buffer with 1
mol/l KCl, and washing again in low-salt buffer. Pro-
teins were eluted from the beads with 200 mmol/l imi-
dazole in low-salt buffer, then the imidazole removed
by dialysis. GST-tagged proteins were purified on glu-
tathione-Sepharose 4B columns (Amersham Bios-
ciences), using low and high salt buffers as above. To
remove contaminating nucleic acids, benzonase was
first added to bacterial extracts and again during
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based pull-downs were performed in binding buffer
(20 mmol/l Tris-HCl pH 8, 100 mmol/l NaCl, 0.05%
Triton X-100) containing benzonase, for 2 hours at 4°
C. Washes were performed in binding buffer, followed
by washes in high salt wash buffer (20 mmol/l Tris-
HCl pH8, 400 mol/l NaCl, 0.05% Triton X-100). GST
pull-downs on ES cell nuclear extracts were performed
using the binding and washing conditions as described
in the IP section.
Size fractionation of protein complexes was performed
on a fast protein liquid chromatography apparatus
(AKTA FPLC; Amersham Biosciences) with a Superose
6 10/30 column (Amersham Biosciences). Fractions
were precipitated with 100% trichloroacetic acid and
analyzed by western blotting as described previously
[51]. Molecular size standards were thyroglobulin (670
kDa) and albumin (66 kDa) (Amersham Biosciences).
SDS-PAGE, western blotting and EMSA
Bound proteins were eluted from beads by boiling in
sample buffer (1 × Laemmli buffer). For western blot ana-
lysis, samples were separated by electrophoresis in SDS
polyacrylamide gels and blotted onto poly(vinylidene
fluoride membranes), (MilliPore) using a semi-dry blot-
ting apparatus (BioRad). Signal detection was performed
using enhanced chemiluminescence (Amersham).
For EMSA or band-shift analysis, protein extracts were
preincubated with bandshift buffer (10% glycerol,
20 mmol/l Hepes pH7.4, 20 mmol/l KCl, 1 mmol/l
MgCl2, 5 mmol/l dithiothreitol (DTT), 10 μmol/l ZnCl2,
100 μg/ml bovine serum albumin (BSA), 0.02% NP40)
and 2 to 4 μg of salmon sperm DNA as a non-specific
competitor. The reaction was incubated for 20 minutes
at room temperature. Upon addition of probe the binding
reaction was performed for another 20 minutes. Com-
plexes were analyzed by electrophoresis through a 5%
acrylamide (37,5:1) 0.5 × Tris/borate/EDTA non-
denaturing gel at 8V/cm
2 at 4°C. Where specified, 300-
fold excess of unlabeled probe or specific competitor was
added at the same time as the probe.
Mouse probes for EMSA were end-labeled with
32P,
whereas human probes (MYC-N, H42.1 rDNA and
H37.9 rDNA) were
32P-labeled PCR fragments. For
EMSA with in vitro methylated probes, purified H37.9
and H42.1 rDNA fragments (5 μl) were methylated in
vitro using 12 U SssI methyltransferase (New England
Biolabs) and 1 μl S-adenosyl-L-methionine (32 mmol/l)
in a final volume of 30 μl. Reactions were performed
twice for 4 hours at 37°C, after which probes were puri-
fied. For supershift experiments, 1 μl of anti-CTCF
mouse monoclonal or anti-actin (used as non-specific
antibody) was added to the binding reaction before the
radiolabeled probe.
ChIP
Preparation of cross-linked chromatin (2 × 10
7 cells
treated with 1% formaldehyde for 10 minutes at room
temperature), sonication of chromatin to yield fragments
of 300 to 800 bp, and immunoprecipitation were per-
formed as described in the Upstate protocol http://www.
upstate.com. At least two independent ChIPs were car-
ried out per experiment. For streptavidin ChIPs, minor
modifications were used: streptavidin beads were
blocked for 1 hour at room temperature in 0.2 mg/ml
sonicated salmon sperm DNA, elution was performed
for 16 hours at 65°C in elution buffer (0.1% NaHCO3,
1% SDS, 0.2 mol/l NaCl). Quantitative real-time PCR
(Opticon I, MJ Research and MyiQ, BioRad) was per-
formed using SYBR Green (Sigma), Platinum Taq DNA
polymerase (Invitrogen) and 100 ng of each primer
under the following cycling conditions: 95°C for 3 min-
utes, followed by 40 cycles of 10 seconds at 95°C, 30
seconds at 60°C and 15 seconds at 72°C (during which
measurements were taken). Values were normalized to
input measurements, and enrichment was calculated
relative to the Amylase gene using the comparative Ct
method. PCR products were all < 150 bp.
For ChIP analysis with nuclei derived from human cell
lines, 5 × 10
7 cells were fixed in 1% formaldehyde, lysed
and sonicated. ChIP was performed using Dynabeads-
protein G (Dynal Biotech) coupled to anti-CTCF, anti-
CTCFL or anti-UBF antibodies. Dynabeads were incubated
with lysates for 4 h at 4°C, and washed consecutively with
commercial buffers (Low Salt, High Salt and LiCl Immune
Complex Wash Buffers; Upstate). Chromatin was eluted
with 200 μl of elution buffer (Upstate), de-crosslinked for
8 hours at 65°C, and purified (Qiaquick columns; Qiagen).
Real-time PCR of immunoprecipitated DNA was per-
formed with primers shown in Table S7 (see Additional
file 17). The MYC-N and NY-ESO1 amplicons were used
as positive controls for CTCF and CTCFL, respectively,
and the MYC-H.1 amplicon as negative control. Enrich-
ment for a specific DNA sequence was calculated as
above.
Methylation-sensitive ChIP assay (ChIP-chop)
To analyze the methylation density of rDNA precipi-
tated with CTCF antibodies, post-ChIP hydrolysis
(’chopping’) of DNA was performed using the methyla-
tion sensitive enzyme HpaII and its isoschizomer MspI.
I n p u ts a m p l e( 6 0n g )a n dD N Af r o mt h eC T C FC h I P
reaction were divided into three equal aliquots, which
were digested with HpaII or MspI, or left undigested
(mock digested control). Digestions were carried out in
af i n a lv o l u m eo f2 0μl for 3 hours at 37°C. Enzymes
were inactivated for 30 minutes at 65°C. From each
digestion, 10 μl was subjected to quantitative PCR with
H42.1 rDNA primers, as described above. The uncut
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MspI resistance was calculated as a percentage of mock
digested DNA, by measuring the difference in Ct values
in the qPCR (mock-MspIo rm o c k - HpaII), taking the
inverse of the fold difference in expression level, and
multiplying this value by 100.
Cell lines, transfections and lentiviral transduction
To generate the Ctcf
bio-neo knock-in allele, a CTCF-TEV-
bio in-frame fusion DNA was generated by PCR. In this
construct, the biotinylation sequence [19] is preceded by
at o b a c c oe t c hv i r u s( T E V )p r o t e a s ec l e a v a g es i t eo f
seven amino acids. The neomycin-resistant LoxP-Neo-
loxP vector and targeting procedures have been described
previously [51]. IB10 129 ES cell DNA was analyzed by
Southern blotting using radiolabeled probes outside of
the region of homology (Figure 1A). For confirmation of
homologous recombination, we used different 5’ end and
3’ end probes, and a PCR-based genotyping assay.
Ctcf
bio-neo ES cells were transfected with CMV-Cre to
remove the neomycin resistance cassette. A second
round of homologous recombination was performed to
target the Rosa26 locus with hemagglutinin (HA)-tagged
BirA [20]. Verification of homologous recombined
clones was performed by PCR. Control BirA-positive ES
cell lines have been described previously [20].
3T3L1 cells (CL-173; ATCC) [29] and 293T cells [10]
were cultured as described previously. The Ctcf
f/f pri-
mary MEFs were isolated as described previously [51] at
embryonic day 13.5 from embryos derived from condi-
tional Ctcf
f/f knockout mice [31].
Transient transfections in 293T cells with Flag-UBF
and pcDNA3-CTCFL were performed using a transfec-
tion reagent (Lipofectamine™2000; Invitrogen) in
reduced serum media (Optimem; GibcoBRL). Cells were
analyzed 24 hours after transfection. Cre-lentivirus pro-
duction and transduction of confluent primary MEFs
was performed as described [10], with the exception
that cells were split and diluted two-fold at 24 hours
after transduction. Virus titers and Cre functionality
were tested using serial dilutions. Recombination was
tested after 4 days of infection by quantitative RT-PCR.
KCTCFD11 is a sub-line derived from K562 myeloid
leukemia cells, which is stably transfected with a consti-
tutive CTCF expression vector that moderately overex-
presses CTCF (two to three-fold) compared with cells
transfected with the empty vector (KpCDNA subline)
[52]. For EMSA experiments, 293T cells or K562 cells
were transfected with pcDNA3-CTCF expression vector
(Lipofectamine™2000; Invitrogen).
Northern blot analysis
Total RNA was isolated using an isolation solvent
(RNA-Bee RNA Isolation Solvent; Tel-Test Inc.), size
separated by gel electrophoresis (~6 μg per lane) and
blotted onto membrane (Hybond N+; Amersham).
Probes were radioactively labeled by PCR. Blots were
exposed to screens (PhophorImager; Molecular
Dynamics) to quantify results.
Nuclear run-on
Cells were collected and washed twice with cold phos-
phate-buffered saline (PBS). The cells were lysed
in nuclear isolation buffer (10 mmol/l Tris pH7.5;
10 mmol/l NaCl, 10 mmol/l MgCl2,0 . 5 %N P 4 0 ) .T h e
nuclei were spun at 1000 g and resuspended in storage
buffer (50 mmol/l Tris pH8.5, 0.1 mmol/l EDTA,
5m m o l / lM g C l 2, 40% glycerol). Approximately 10
6
nuclei (50 μl) were pre-incubated for 20 minutes on ice
with 100 μg/ml a-amanitin. Nuclei were then mixed
with 50 μl 2 × reaction buffer (300 mmol/l KCl,
5 mmol/l MgCl2, 10 mmol/l Tris pH 7.5, 5 mmol/l
DTT, 20 U RNA Guard, 0.5 mmol/l of each ATP, UTP
and GTP, and 100 μCi of a
32PC T P( 8 0 0C i / m m o l ,
10 mCi/ml); Amersham). The labeling reaction was per-
formed for 30 minutes at 30°C. The reaction was
stopped on ice by adding 1 ml of isolation solvent
(RNA-Bee) and total RNA was extracted as indicated
above. Using a slot blot hybridization system with nylon
membranes (Hybond-N+), 5 μgo fD N AP C Rf r a g m e n t s
were hybridized with2×10
5 cpm of labeled RNA. Hybri-
dization and detection was performed as described
above. Incubation was performed in 2 ml of Church
hybridization mix (0.5 mol/l Na2HPO4 pH 7.2, 7% SDS,
1 mmol/l EDTA) in a rotating hybridizer at 65°C for
24 h. Membranes were washed extensively at 65°C with
Church wash buffer (40 mmol/l Na2HPO4 pH 7.2, 1%
SDS). Hybridization signals were quantified with an ima-
ger (Phosphor Imager; Typhoon Amersham) using Ima-
gequant software. The signal was corrected for the
amount of CTG in the probe.
Real-time PCR on ES cell RNA
Total ES cell RNA was isolated using Trizol (Invitrogen),
treated with DNAseI, and converted into cDNA using ran-
dom hexamers and reverse transcriptase (Superscript II;
Invitrogen). Real-time PCR was performed using specific
rRNA-covering primers and Sybr Green mix (Quantitect;
Q i a g e n )o nap e r f o r m e do na na u t o m a t e dP C Rs y s t e m
(7500 Fast RT-PCR; Applied Biosystems). The negative
control was as above with omission of the reverse tran-
scriptase. The obtained Ct values were normalized to the
Ct value of Hprt.
FISH and immunofluorescence analysis
For FISH in ES cells, the cells were grown on coverslips.
RNAi treatment of the cells was performed using a pSU-
PER vector-based system (CTCF RNAi sequence:
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fection, cells were treated with puromycin to positively
select for infected cells, thereby increasing the number
of cells in which CTCF was knocked down. After 4 days
of RNAi treatment, cells were fixed for 10 minutes with
4% paraformaldehyde (PFA) in PBS. Slides were stored
in 70% ethanol until further use. For RNA FISH, cells
were pretreated by two PBS washing steps, followed by
a permeabilization step of 5 minutes in a solution of 25
μg/ml proteinase K in PBS. Slides were washed once in
PBS, dehydrated and hybridized as described previously
[53]. For DNA FISH, slides were pretreated by two PBS
washing steps followed by a permeabilization step
(4 minutes incubation in 0.1% pepsin in 0.01 mol/l HCl
at 37°C). Slides were washed once in PBS on ice and
fixed again for 5 minutes in 4% PFA in PBS. Slides were
washed twice in PBS and dehydrated. Denaturation was
performed for 2 minutes at 80°C in denaturing solution
(70% formamide, 2 × saline sodium citrate, 10 mmol/l
phosphate buffer pH 7), after which the slides were
cooled in 70% ethanol, dehydrated, and hybridized as
described previously [53].
T h eu n s t a b l e5 ” external transcribed spacers (ETS)
probe has been described previously [32]. The enhancer
probe used for DNA and RNA FISH (ncRNA; see Figure
7A for its position) was isolated as a 1.7 kb SalIf r a g -
ment from a cosmid covering a large part of the mouse
rDNA repeat [32]. Probes were labeled by nick transla-
tion (Roche) using digoxygenin or biotin. Control DNA
FISH experiments in ES cells showed that the ncRNA
probe specifically localized to the nucleolus, as on pro-
metaphase chromosomes the probe localized in discrete
spots adjacent to centromeric DNA, indicative of NORs
(see Additional file 11, Figure S10A), whereas in inter-
phase cells the ncRNA probe localized within the
nucleolus (see Additional fil e1 1 ,F i g u r eS 1 0 B ) .T h e s e
data strongly suggest that the ncRNA probe specifically
recognizes rDNA. When ES cells were treated with
a-amanitin to inhibit RNA polymerase II transcription,
both ncRNA and pre-rRNA signals remained visible
(data not shown), confirming that RNA polymerase I is
responsible for transcription of spacer and gene
promoters.
For immunofluorescence staining, cells were fixed in
4% PFA in PBS for 15 minutes at room temperature,
permeabilized in 0.15% Triton X-100 in PBS, blocked in
1% BSA in PBS and incubated with antibodies as
described previously [32,51]. Images of cells were col-
lected with a microscope (DMRBE; Leica) equipped with
a camera (ORCA ER; Hamamatsu) or with a confocal
lens (LSM510; Zeiss), as described previously [51].
For quantification of pre-rRNA signals, images of ES
cells were collected with a microscope (DMRBE; Leica),
using the same exposure time for all images. Five images
each were collected of non-treated ES cells, control
RNAi-treated ES cells and CTCF RNAi-treated ES cells.
Collectively, more than 300 cells were present in the
images, which were imported into Image J software
(Rasband W.S., ImageJ, U. S. National Institutes of
Health, Bethesda, Maryland, USA; 1997 to 2008; http://
rsb.info.nih.gov/ij/,). Regions of interest (ROIs) were
placed around individual pre-rRNA signals, using the
freehand tool of Image J. ROIs were saved with the ROI
manager. Both background fluorescence and mean
fluorescent intensities of ROIs were calculated in each
image. After deduction of the background fluorescence,
mean fluorescence intensity data were collected into a
spreadsheet (Excel; Microsoft), pooled and analyzed
(Aabel software; GigaWiz). Quantification was per-
formed in two independent experiments using different
ES cell cultures, different probes and different RNAi
treatments. Both experiments yielded similar results;
t h a ti s ,k n o c k - d o w no fC T C Fl e a d st om i l d l yr e d u c e d
pre-rRNA levels.
Additional material
Additional file 1: Figure S1: Characterization of CCCTC binding
factor (CTCF) and biotin tagged CTCF (CTCF-bio) interactions. (A)
CTCF-bio interacts with known CTCF binding partners. To identify CTCF-
interacting proteins, CTCF-bio was purified from embryonic stem (ES) cell
nuclear extracts under mild conditions. We validated our approach by
showing that known interaction partners of CTCF, such as Yin Yang (YY)-
1 [54], poly(ADP-ribose) polymerase (Parp)1 and nucleophosmin [42] co-
precipitate with CTCF-bio. (B) CTCF-bio interacts with upstream binding
factor (UBF) in vivo. Streptavidin pull-downs were performed using lung
nuclear extracts isolated from mice expressing biotinylated (CTCF-bio) or
normal (-) CTCF. Western blot analysis (b = bound fraction, i = input
(5%)) revealed that CTCF-bio interacts with UBF. (C) Immunoprecipitation
(IP) analysis of CTCF and UBF. IP was carried out on extracts of ES cells
expressing both CTCF and CTCF-bio. We used specific antibodies against
CTCF and UBF to precipitate endogenous proteins (IgG = control rabbit
IgG). CTCF-bio was detected with horseradish peroxidase-coupled
streptavidin. B = bound fraction, i = input (5%).
Additional file 2: Table S1: Mass spectrometry results for biotin
tagged CTCF (CTCF-bio).
Additional file 3: Figure S2: Direct interaction of CCCTC binding
factor (CTCF) and CTCFL with UBF. (A) Schematic representation of the
glutathione-S-transferase (GST)- and histidin (His)-tagged fusion proteins
used. (B) Expression of GST- and His-tagged fusion proteins. Proteins
were expressed in bacteria and affinity purified. Fusion proteins are
indicated by asterisks. (C) Interaction between bacterially produced
proteins. Purified GST- and His-tagged fusion proteins were incubated
together, followed by GST pull-down. Western blots were incubated with
an anti-His antibody. The experiments revealed a direct interaction
between the CTCF and CTCFL zinc finger (ZF) domains and the
upstream binding factor (UBF) dimerization domain plus high mobility
group (HMG)-box 1. His-tagged proteins containing either the
dimerization domain of UBF or HMG-box 1 only weakly bound CTCF and
CTCFL, indicating that both regions are necessary for efficient interaction.
(D) Bacterially produced CTCF and CTCFL interacted with UBF derived
from embryonic stem (ES). GST pull-down assays of bacterially produced
CTCF and CTCFL mutants were performed with nuclear protein extracts
from ES cells. Equal amounts of GST fusion proteins were incubated with
nuclear extracts from ES cells. Binding was performed under low-salt
conditions, and washing was performed under more stringent
conditions. Western blots were incubated with an antibody against UBF
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able to pull down specifically UBF. The ZF domains of CTCF (1) and
CTCFL (5) displayed prominent interaction with ES cell-derived UBF. (E)
Bacterially produced ZFP37 did not interact with histidine (His)-tagged
UBF. The ZF domain of murine ZFP37 a protein that is enriched in the
nucleolus [55] was tagged with GST. To provide further evidence for the
specificity of the CTCF-UBF interaction, we examined whether this ZF
domain interacts with UBF. Purified GST-tagged ZFP37 was incubated
with His-tagged UBF (constructs 9, 10, 13). The interaction between CTCF
(construct 1) and UBF was clear, but we could not detect any binding
between UBF and ZFP37.
Additional file 4: Figure S3: Both CCCTC binding factor (CTCF) and
biotin-tagged CTCF (CTCF-bio) bind the ribosomal (r)DNA spacer
promoter in vivo. Extracts of adult thymus from wild type and Ctcf
bio/+;
Rosa26
bira/+ mice were analyzed for CTCF and CTCF-bio binding to the
rDNA spacer promoter using anti-CTCF antibodies or a control serum (-).
Additional file 5: Figure S4: Comparison of mouse, rat and hamster
ribosomal (r)DNA repeat regions. Comparison of nucleotide sequences
of the mouse, rat and hamster rDNA repeats [27]. Only the regions
around the spacer promoter are indicated. Numbers to the left indicate
distance (in base pairs) from the transcription start site of the gene
promoter. The CCCTC binding factor (CTCF) consensus site [3] is
underlined. Highly conserved CTCF consensus site residues are indicated
by a dot (the asterisk indicates deviation between consensus site
prediction and real residue). Conserved CpG dinucleotides are boxed.
The transcription start site of the spacer promoter is indicated by a right-
pointing arrow.
Additional file 6: Figure S5: Comparison of mouse and human rDNA
repeat regions. (A-C) Matrix plot comparisons of nucleotide sequences
of (A) mouse versus mouse, ((B) human versus human and (C) human
versus mouse rDNA repeats in the region upstream of the gene
promoter. CCCTC binding factor (CTCF) binding sites are indicated
(mCTCF BS for mouse, H37.9 and H42.1 for human). A highly repetitive
Alu sequence is present ~2.5 kb upstream of the gene promoter of the
human rDNA. Mouse rDNA does not have this repeat, but instead
contains the well known ‘enhancer repeat’ region. Why CTCF binds twice
in human and only once in mouse rDNA is unclear. One possibility is
that CTCF has additional regulatory functions in the human rDNA repeat.
For example, the H37.9 site is conserved in the rDNA of the great apes,
as is the highly repetitive Alu repeat [56]. We speculate that H37.9 might
be linked to the presence of this repetitive region in human and great
ape rDNAs. (D) Similar chromatin organization of mouse and human
rDNA repeat regions upstream of the gene promoter. The upper line
represents the mouse rDNA (enhancer repeats are indicated by the open
rectangles), and the lower line represents the human repeat. Only
regions upstream of the gene promoter are shown. Right-pointing
arrows indicate transcription from the gene promoter, giving rise to pre-
rRNA. The spacer promoter has been clearly identified for the mouse but
its location has not yet been mapped accurately for the human RNA.
The chromatin organization surrounding the CTCF binding site (indicated
by a lollipop) that is most proximal to the gene promoter, is strikingly
similar in both mouse and human. In both organisms, the CTCF binding
sites are embedded within a CpG island (as predicted with EMBOSS-CpG
Plot [57]; the length of the CpG domains is indicated below the
respective rDNAs). Immediately upstream of the CTCF binding site,
mouse rDNA chromatin is enriched in ‘active’ histone modifications. A
surprisingly similar result was previously obtained in the human locus
(see Figure 5, site H42 in the paper by Grandori et al. [36]). Furthermore,
TATA binding protein (TBP) has been shown to accumulate near the
CTCF binding site, both in human [36] and mouse [25] rDNA repeats. We
therefore propose that the spacer promoter in the human rDNA is
located immediately downstream of the H42.1 CTCF binding site.
Additional file 7: Figure S6: CCCTC binding factor (CTCF) and CTCFL
interact with human ribosomal (r)DNA in vivo. (A) Chromatin
immunoprecipitation (ChIP) analysis on human rDNA. ChIP analysis with
CTCF, CTCFL (two independent antibodies (Abs) were used) and UBF
antisera, showing binding to the IGS of the rDNA repeat (sites H4, H37.9
and H42.1). Chromatin was prepared from non-transfected K562 cells or
from cells stably transfected with CTCF (KCTCFD11) or the empty vector
(KpCDNA). Relative enrichment was quantified by real-time PCR with the
indicated primer sets. Known CTCF (MYC-N) and CTCFL (NY-ESO1) target
sites were used as positive control for ChIP. Data were normalized
against the enrichment for the negative control MYC-H.1. The value for
the amount of PCR product present from the ChIP assay without
antibody was set as 1 (white bars). Error bars represent the SEM of five
to seven independent experiments for CTCF, eight to 10 for upstream
binding factor (UBF), and four for CTCFL. (B) Sequential ChIP (ChIP-
reChiP) analysis on human rDNA. Primary ChIP was performed as above,
and CTCF or UBF ChIP products were subjected to a second
immunoprecipitation (reChIP) with anti-UBF or anti-CTCF antisera,
respectively. Relative enrichment was quantified by real-time PCR with
primers for H37.9 or H42.1 rDNA, and data were normalized as in part
(A). Error bars represent SEM of three independent experiments. Results
show in vivo binding of CTCF and UBF simultaneously at rDNA sites. (C)
CTCF interacts with human rDNA in vitro. Electrophoretic mobility shift
assay (EMSA) analysis with nuclear extracts from 293T cells or K562 cells
transfected with CTCF or mock transfected.
32P-labeled PCR fragments of
MYC-N (positive control), H42.1 rDNA and H37.9 rDNA were used as
probes. Unlabeled (cold) probes were used as competitors (Myc-N = 90%
competition (compare lanes 1 and 3); H42.1 = 95% competition
(compare lanes 5 and 7); H37.9 = 85% competition (compare lanes 11
and 13). Arrowheads indicate binding of CTCF; asterisks indicate
supershift bands that appear after incubation with anti-CTCF antibody.
Additional file 8: Figure S7: CCCTC binding factor (CTCF) binds
human ribosomal (r)DNA in a methylation-sensitive manner. (A)
Influence of methylation on the binding of CTCF to mouse rDNA. Band-
shifts were performed using the mouse rDNA probe (R30) and the same
probe methylated on two cytosine residues (R30-CmE). Competition was
assessed by adding increasing amounts of unlabeled probe. (B) Control
and SssI methyltransferase-treated H37.9 and H42.1 rDNA probes were
digested with the methylation-sensitive enzyme HpaII to assess the level
of in vitro methylation. Fragments were separated in 8% polyacrylamide
gels.
Additional file 9: Figure S8: Chromatin immunoprecipitation (ChIP)
analysis in embryonic stem (ES) cells. (A) Outline of mouse rDNA
repeat. The position of the primer pairs used in the ChIP in panel B is
indicated by downward-pointing arrows. Transcription initiation from the
spacer promoter (yielding ncRNA) and the gene promoter (yielding pre-
rRNA) is indicated by right-pointing arrows. The 47S pre-rRNA is divided
into 5’ and 3’ external transcribed spacer (ETS), internal transcribed
spacers (ITS), and 18S, 5.8S and 28S rRNA genes. The approximate
positions of the CCCTC binding factor (CTCF) consensus site (gray box)
and enhancer repeats (white boxes) are indicated. (B) ChIP assay on
mouse rDNA. Binding of CTCF (black), upstream binding factor (UBF)
(purple/blue) and RNA polymerase I (red) to mouse rDNA was analyzed
using the primer pairs indicated in part (A). Embryonic stem (ES) cells
were treated with control (straight lines) or Ctcf (stippled lines) RNAi
constructs. ES cell nuclei were fixed with 1% formaldehyde, and protein-
DNA complexes were immunoprecipitated with antibodies against the
indicated proteins. Upon depletion of CTCF, binding of both RNA Pol I
and UBF was diminished. Strikingly, for both proteins, loss in binding was
greatest near the CTCF binding site, strongly suggesting an important
role for CTCF in the binding of these proteins at or near the spacer
promoter (RNA Pol I, UBF) and on the enhancer repeat (UBF). The fact
that RNA Pol I binding was not affected at or downstream of the gene
promoter is consistent with previous data.
Additional file 10: Figure S9: CCCTC binding factor (CTCF) regulates
histone deposition. (A) Binding of histone H3 to mouse ribosomal (r)
DNA. Chromatin immunoprecipitation (ChIP) analysis is the same as
shown in Figure 6, but a lower y-axis scale is used to demonstrate the
histone H3 binding pattern. Enrichment was normalized to input and is
shown relative to the Amylase gene (note that in this case the Amylase
gene is not a negative control, because histone H3 will also bind this
gene, hence the ‘low’ relative enrichment). Histone H3 was distributed in
a similar manner in Cre-treated Ctcf
f/f mouse embryonic fibroblasts
(MEFs) compared with non-treated cells. Interestingly, binding appeared
to diminish as the ribosomal gene promoter area is approached. This
might be due to the fact that active ribosomal genes contain fewer
nucleosomes [12]. (B) Binding of CTCF and H2A.Z to the c-Myc gene.
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upstream of the c-Myc transcriptional start site (SD of three independent
experiments indicated). The position of the primer sets is indicated with
arrows. (C) Binding of modified and variant histones to human rDNA.
ChIP analysis was performed as in Figure S6A (see Additional file 7).
Chromatin was prepared from K562 cells. Protein-DNA complexes were
immunoprecipitated with antibodies against the indicated proteins. ChIP
analysis showed specific binding of H2A.Z, H3ac and H3K4me2 to sites
H37.9 and H42.1 of the rDNA.
Additional file 11: Figure S10: Spatial segregation of non-coding
(nc)RNA and pre-rRNA transcription.A ,(B) DNA fluorescent in situ
hybridization (FISH) analysis. The ncRNA probe (biotin-labeled, green) was
hybridized to fixed and denatured ES cells. (A) Cell in prometaphase,
with chromosomes condensed but not yet aligned. The ncRNA probe
localized in distinct spots (arrows) adjacent to the strongly 4’,6-
diamidino-2-phenylindole (DAPI)-stained centromeric DNA. (B) An
interphase cell, with the ncRNA probe localized to the nucleolus
(visualized as weakly staining DAPI regions). Scale bars = (A) 2 μm, (B)
3 μm. (C-F) RNA FISH analysis. The ncRNA probe (biotin-labelled, green)
and pre-rRNA probe (digoxygenin-labeled, red) were hybridized to fixed
non-denatured ES cells. (C-E) Embryonic stem (ES) cells contain normal
levels of CCCTC binding factor (CTCF), whereas (F) ES cells transfected
with a pSUPER plasmid have CTCF knockdown. (C) Low resolution image
of a small ES cell colony (cells in the middle are less well visualized
because these cells grow in clumps). Multiple nuclei (one is outlined),
particularly on the edge of the colony, had readily detectable ncRNA and
pre-rRNA signals. Scale bar = 10 μm. (D) High resolution confocal image
of a single DAPI-stained ES cell nucleus. Both ncRNA and pre-rRNA
signals were localized exclusively to the three nucleoli present within this
cell. Five ncRNA spots are visible (arrows), localized at the periphery of
the nucleoli. Scale bar = 1 μm. (E, F) Confocal images taken with similar
settings. (E) non-treated ES cells; (F) CTCF RNAi-treated ES cells. The
ncRNA signal is indicated by arrows. Depletion of CTCF led to a
reduction in ncRNA. ncRNA was lacking in many cells throughout a 3D
confocal stack. In cells lacking ncRNA, pre-rRNA levels also seemed to be
affected (see asterisks). Scale bars (E, F) = 8 μm. (G) Knock-down of CTCF
in ES cells. ES cells were transfected with a pSUPER plasmid to knock
down CTCF. After 4 days, < 50% of the cells expressed detectable levels
of CTCF (red), as detected by immunofluorescent staining with anti-CTCF
antibodies. Nuclei were stained with 4’,6-diamidino-2-phenylindole
(DAPI). By contrast, cells treated with a control RNAi vector all expressed
CTCF (not shown). Scale bar = 8 μm.
Additional file 12: Table S2: Primers used for band-shift assays [58].
Additional file 13: Table S3: Primers used for genotyping.
Additional file 14: Table S4: Primers used for mouse chromatin
immunoprecipitation (ChIP).
Additional file 15: Table S5: Primers used for northern blotting and
nuclear run-on assays.
Additional file 16: Table S6: Primers used for real-time PCR on
embryonic stem (ES) cell ribosomal (r)RNA.
Additional file 17: Table S7: Primers used for human chromatin
immunoprecipitation (ChIP) and band-shift assays [59-61].
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